This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (711) Chronic Conditions (465) Protocols for Public Health Research and Surveillance (118) Systematic Review Protocols (353) Infectious Diseases (non-STD/STI) (1739) Gastroenterology and Hepatology (140) Pharmacovigilance (178) Secondary Use of Clinical Data for Research and Surveillance (487)

Published on in Vol 14 (2025)

This is a member publication of University College London (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68113, first published .
Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Authors of this article:

Kurinchi Selvan Gurusamy1, 2 Author Orcid Image ;   Christian Gluud2, 3, 4 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Kumburegama B, Kristensen A, Bjelakovic G, Nikolova D, Asante M, Bjelakovic M, Koretz R, Balakumar M, Michelsen M, Klingenberg S, Gluud C. Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies. Systematic Reviews 2026 View